21062 ⎘
Medicinal preparations containing antigens or antibodies; Vertebrate antigens Nervous system antigens; Prions
Prevention and treatment of amyloidogenic disease
#302ANTI-AMYLOID IMMUNOGENIC COMPOSITIONS, METHODS AND USES
#303METHODS AND MATERIALS FOR PRODUCING A GENERIC ANTI-AMYLOID IMMUNE RESPONSE IN MAMMALS
#304Preventive And Therapeutic Vaccine For Huntington's Disease
#305PREVENTIVE AND THERAPEUTIC VACCINE FOR ALZHEIMER'S DISEASE
#306Antigen Arrays for Treatment of Allergic Eosinophilic Diseases
#307Transgenic animal model for alzheimer's disease
#308Peptide conjugate compositions and methods for the prevention and treatment of alzheimer's disease
#309NOVEL METHOD FOR DOWN-REGULATION OF AMYLOID
#310Immunological control of beta-amyloid levels in vivo
#311Humanized antibodies that recognize beta amyloid peptide
#312Methods of treating dementia by administering virus-like particles coupled to Aβ
#313Monoclonal antibody
#314Method of Treating Cognitive Decline and Synaptic Loss Related to Alzheimer's Disease
#315Methods of Cell Therapy, Neurogenesis and Oligodendrogenesis
#316Method for preventing and treating Alzheimer's disease
#317Prevention, treatment and diagnosis of diseases associated with beta-amyloid formation and/or aggregation
#318A-BETA IMMUNOGENIC PEPTIDE CARRIER CONJUGATES AND METHODS OF PRODUCING SAME
#319Methods and compositions involving polymeric immunoglobulin fusion proteins
#320Treatment and prevention of neurodegenerative diseases using gene therapy
#321Soluble Hybrid Prion Proteins And Their Use In The Diagnosis, Prevention And Treatment Of Transmissible Spongiform Encephalopathies
#322HUMANIZED ANTIBODIES THAT RECOGNIZE BETA AMYLOID PEPTIDE
#323ACTIVE IMMUNIZATION TO GENERATE ANTIBODIES TO SOLUBLE A-BETA
#324METHOD FOR REDUCING NEURONAL DEGENERATION BY ADMINISTERING CNS-DERIVED PEPTIDES OR ACTIVATED T CELLS
#325Encapsulated amyloid-beta peptides
#326Molecular antigen arrary
#327Prevention and treatment of amyloidogenic diseases
#328Prevention and treatment of amyloidogenic diseases
#329Therapeutic Strategy for Treating Autoimmune and Degenerative Diseases
#330IMMUNIZATION AGAINST AMYLOID PLAQUES USING DISPLAY TECHNOLOGY
#331PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASE
#332Prevention and treatment of amyloidogenic disease
#333Humanized antibodies that recognize beta amyloid peptide
#334Methods and compositions to treat misfolded-SOD1 mediated diseases
#335Aβ immunogenic peptide carrier conjugates and methods of producing same
#336Adjuvation Through Cross -Beta Structure
#337PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASE
#338Vaccine And Method For Treatment Of Neurodegenerative Diseases
#339Variant Amyloid Protein
#340Combination therapy for the treatment of Alzheimer's disease
#341Humanized antibodies that recognize beta amyloid peptide
#342METHOD OF INDUCING TOLERANCE TO BETAAP 1-42 AND MYELIN BASIC PROTEIN
#343Methods and compositions to treat and detect misfolded-SOD1 mediated diseases
#344Method for improving memory in AD patients
#345Compositions and Methods for Treating Neurological Diseases
#346Vaccine for the prevention and treatment of Alzheimer's and amyloid related diseases
#347Anti-amyloid immunogenic compositions, methods and uses
#348Amyloid beta peptide analogs and assemblies thereof
#349Immunizing compostion and method for inducing an immune response against the beta-secretase cleavage site of amyloid precursor protein
#350A-β immunogenic peptide carrier conjugates and methods of producing same
#351Vaccine for the Prevention and Treatment of Alzheimer's and Amyloid Related Diseases
#352Immunogenic peptide carrier conjugates and methods of producing same
#353Antigen arrays for treatment of bone disease
#354Anti-candida agents for the treatment of prion diseases
#355Amyloid β(1-42) oligomers, derivatives thereof and antibodies thereto, methods of preparation thereof and use thereof
#356Antigen arrays for treatment of allergic eosinophilic diseases
#357Angiotensin peptide-carrier conjugates and uses thereof
#358Mucosal immunization to prevent prion infection
#359Molecular antigen array
#360NOVEL METHOD FOR DOWN-REGULATION OF AMYLOID
#361Adjuvant combination formulations
#362Immunogens and corresponding antibodies specific for high molecular weight aggregation intermediates common to amyloids formed from proteins of differing sequence
#363Active or passive immunization against proapoptotic neurotrophins for the treatment and/or prevention of neurodegenerative diseases
#364Compositions and methods for diagnosing and treating retinal diseases
#365Immunological control of beta-amyloid levels in vivo
#366Active immunization to generate antibodies to solble a-beta
#367Methods for assessing antibodies to neurodegenerative disease-associated antigens
#368Preventives/remedies for neurodegenerative diseases
#369Chimeric peptides as immunogens, antibodies thereto, and methods for immunization using chimeric peptides or antibodies
#370Angiotensin peptide-carrier conjugates and uses thereof
#371Methods and compositions comprising supramolecular constructs
#372Antigen-presenting cells for neuroprotection and nerve regeneration
#373Prevention and treatment of amyloidogenic disease
#374Immunizing composition and method for inducing an immune response against the β-secretase cleavage site of amyloid precursor protein
#375Prevention and treatment of amyloidogenic disease
#376Production of stabilized conformational isomers of disease associated proteins
#377Prevention and treatment of amyloidogenic disease
#378Prevention and treatment of amyloidogenic disease
#379Humanized antibodies that recognize beta amyloid peptide
#380Method for neuronal protection in amyotrophic lateral sclerosis by a vaccine comprising Copolymer-1 or Copolymer-1 related peptides
#381Prevention and treatment of amyloidogenic disease
#382Ghrelin-carrier conjugates
#383Prevention and treatment of amyloidogenic disease
#384Prevention and treatment of amyloidogenic disease
#385Prevention, treatment and diagnosis of diseases associated with beta-amyloid formation and/or aggregation
#386Anti-amyloid β antibodies
#387Prevention and treatment of amyloidogenic disease
#388Treatment of tse infection
#389Novel method for down-regulation of amyloid
#390Agents and compositions and methods utilizing same useful in diagnosing and/or treating or preventing plaque forming diseases
#391Immunological control of β-amyloid levels in vivo
#392Prevention and treatment of amyloidogenic disease
#393Amyloid beta-peptide and methods of use
#394Vaccine for the prevention and treatment of Alzheimer's and amyloid related diseases
#395Agents and compositions and methods utilizing same useful in diagnosing and/or treating or preventing plaque forming diseases
#396Prevention and treatment of amyloidogenic disease
#397Prevention and treatment of amyloidogenic disease
#398Prevention and treatment of amyloidogenic disease
#399Prevention and treatment of amyloidogenic disease
#400Prevention and treatment of amyloidogenic disease
#401Prevention and treatment of synucleinopathic and amyloidogenic disease
#402Prevention and treatment of amyloidogenic disease
#403Prevention and treatment of amyloidogenic disease
#404Prevention and treatment of amyloidogenic disease
#405Prevention and treatment of amyloidogenic disease
#406Prevention and treatment of amyloidogenic disease
#407Humanized antibodies that recognize beta amyloid peptide